There is no carcinogenic effect in the adverse reactions of valsartan, and for those who need to take the drug for a long time, they can take it for a long time in accordance with the doctor’s instructions, and do not have to worry about its carcinogenicity. Valsartan belongs to the angiotensin II receptor antagonist (ARB) class of drugs, through the blockade of angiotensin II receptors, reduce peripheral resistance, to play the role of lowering blood pressure. Valsartan can be taken for a long time, taking 2 years of valsartan does not produce cancer. Valsartan itself does not cause cancer, the Internet rumors of cancer refers to the raw material product impurities in the N-nitrosodimethylamine content exceeds the standard, rather than that the drug is carcinogenic, the two are not the same concept. And for manufacturers who had found out that the impurity content is too high, as early as 5 years ago, the raw materials have been recalled to deal with the current market valsartan can be taken with confidence. Valsartan is suitable for patients with acute coronary syndrome, heart failure, diabetes mellitus and hypertension, and can play a role in protecting target organs and anti-ventricular remodeling, which cannot be replaced by other drugs. Its use in cardiovascular disease is very widespread, and valsartan is more beneficial in patients with a combination of heart failure and proteinuria. Therefore, valsartan generally does not have the possibility of carcinogenicity, you can rest assured that the regular medical institutions to take and buy, the use of drugs need to follow the physician’s instructions, can not change the medication program on their own.